News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Website Goof on False Heart Drug Approval Gives Amarin Corporation PLC (AMRN) a Boost



7/23/2012 8:16:44 AM

Shares of Amarin Corp's (AMRN.O) rose as much as 9 percent to their year high on Thursday morning, after the Irish company accidently put up a website showing that its experimental heart drug had been approved by U.S. drug regulators. The drug, which aims to cut fat content in the blood, is still under marketing review by the U.S. Food and Drug Administration. A decision is expected on July 26. Amarin said in a regulatory filing that the information was inadvertently published through a draft website that is under design by third parties on behalf of Amarin.

Read at Reuters
Read at The Day
Read at News Release


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES